AbbVie presents nine-year CLL14 trial results at EHA congress

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Poolbeg presents preclinical data for POLB 001 at EHA congress Hisse Senetleri 0 3
A Evaxion presents preclinical data for AML vaccine candidate Hisse Senetleri 0 5
A Evaxion presents preclinical data on AML vaccine candidate Hisse Senetleri 0 5
A AbbVie ovarian cancer drug shows 62.7% response rate in trial Hisse Senetleri 0 28
A AbbVie, Philip Morris among market cap stock movers on Wednesday Hisse Senetleri 0 26
A RBC Capital initiates Abbvie stock coverage with outperform rating Hisse Senetleri 0 27
A AbbVie sues US health agency over Botox price controls Hisse Senetleri 0 27
A Raymond James raises Abbvie stock price target to $256 on solid growth Hisse Senetleri 0 47

Benzer konular

Üst